Cancer Research
New biomarker improves early lung cancer detection
October 04, 2025 Image generated by AI
Researchers have identified a novel protein biomarker that detects lung cancer at an early stage with high accuracy. The discovery, detailed in a recent study, could enhance screening methods and improve patient outcomes. Clinical trials showed promising results in identifying the disease before symptoms appear.
Summit's Lung Cancer Drug Shows Promise
Biotech company Summit announced promising results from its lung cancer drug in recent trials. The drug demonstrated potential efficacy in treating advanced cases, marking a step forward in oncology treatments. Further studies are planned to confirm these findings.
DNA scar catalog opens paths to overcome cancer drug resistances
Researchers at Spain's National Cancer Research Centre (CNIO) have developed a comprehensive catalog of mutational 'scars' in DNA caused by cancer. This breakthrough, published in Nature, could help bypass resistances to treatments like PARP inhibitors. The study analyzes thousands of tumor samples to identify key genetic patterns.
Researchers develop AI tool for early cancer detection
September 29, 2025 Reported by AI
Scientists have unveiled a new artificial intelligence model that improves early detection of lung cancer from CT scans. The tool, trained on thousands of images, achieves higher accuracy than traditional methods. This advancement could significantly boost survival rates for patients.
Researchers develop new method for early cancer detection
September 30, 2025 Reported by AI
Scientists at the University of Cambridge have unveiled a groundbreaking blood test that detects cancer earlier than existing methods. The technique analyzes circulating tumor DNA with high accuracy. This innovation could revolutionize screening and treatment worldwide.